Skip to main navigation
Our Science
AT-527
COVID-19
About Atea
About Us
Pipelines & Programs
Leadership
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Careers
Contact
Investor Relations
4
Breadcrumb
Investors
4
> Back to SEC
Go Back
SEC Filing Details
Form
4
Filing Date
February 2, 2022
Document Date
January 31, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filer
VAVRICKA JOHN
Filing Formats
View HTML
Download PDF
Download DOC
Download XLS
Investor FAQs
RSS Feeds
Email Alerts
Contact IR